デフォルト表紙
市場調査レポート
商品コード
1098607

骨髄移植 (BMT) の市場規模・シェア・展望・機会 (2022年~2030年):タイプ・治療タイプ・エンドユーザー・地域別

Bone Marrow Transplant Market, by Type, by Treatment Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 156 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
骨髄移植 (BMT) の市場規模・シェア・展望・機会 (2022年~2030年):タイプ・治療タイプ・エンドユーザー・地域別
出版日: 2022年06月03日
発行: Coherent Market Insights
ページ情報: 英文 156 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

骨髄移植 (BMT) の高度な研究に向けたセンター設立への取り組みが増加しており、世界の骨髄移植 (BMT) 市場の予測期間中の成長を促進すると予測されています。

当レポートでは、世界の骨髄移植 (BMT) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 買収・提携シナリオ
  • 技術概要
  • 規制シナリオ
  • 主な展開
  • PEST分析

第4章 世界の骨髄移植 (BMT) 市場:COVID-19の影響

  • 全体的な影響
  • 政府のイニシアチブ
  • COVID-19:市場への影響

第5章 世界の骨髄移植 (BMT) 市場:タイプ別

  • 概要
  • 自家移植
  • 同種移植
  • その他

第6章 世界の骨髄移植 (BMT) 市場:治療タイプ別

  • 概要
  • 白血病
  • リンパ腫
  • 骨髄腫
  • 骨髄異形成症候群
  • 骨髄増殖性疾患
  • 再生不良性貧血
  • 固形腫瘍
  • 鎌状赤血球貧血
  • サラセミア
  • その他

第7章 世界の骨髄移植 (BMT) 市場:エンドユーザー別

  • 概要
  • 病院
  • 専門クリニック
  • 外来手術センター

第8章 世界の骨髄移植 (BMT) 市場:地域別

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第9章 競合情勢

  • Lonza
  • Merck KgaA
  • Sanofi
  • AllCells
  • STEMCELL Technologies Inc.
  • Charles River Laboratories
  • Beike Biotechnology Co., Ltd.
  • FUJIFILM Cellular Dynamics, Inc.
  • CORESTEM, Inc
  • Gamida Cell
  • Lifeline Cell Technology
  • Mesoblast Ltd
  • PromoCell GmbH

第10章 セクション

目次
Product Code: CMI232

A bone marrow transplant is a medical procedure that replaces the bone marrow with healthy cells. Replacement cells might come from either one's own body or from a donor. A stem cell transplant, or more specifically, a hematopoietic stem cell transplant, is another name for a bone marrow transplant. Transplantation can be used to treat leukemia, myeloma, and lymphoma, as well as other blood and immune system illnesses that impact the bone marrow. Cancer and cancer treatment can damage the hematopoietic stem cells. Hematopoietic stem cells are blood-forming stem cells. Hematopoietic stem cells that are damaged may not develop into red blood cells, white blood cells, or platelets. These blood cells are vital, and each one serves a specific purpose. A bone marrow transplant can help the body regenerate the red blood cells, white blood cells, and platelets it requires.

Market Dynamics

Increasing efforts to set up centers for advanced research for bone marrow transplant (BMT) are expected to drive the market growth over the forecast period. For instance, on May 17, 2022, the Indian Council of Medical Research (ICMR) planned to set up centers for advanced research for bone marrow transplant (BMT) in government hospitals across India. The majority of bone marrow transplant centers are in the private sector, which limits access to treatment for the poor. Under this research model, ICMR will set up multiple centers that will work to provide affordable and safe bone marrow transplant procedures in all six regions of India, including north, south, east, west, north-east and central. The goal of this research model is to contribute towards development of bone marrow transplant, improve access to the established standard of care, and improve the outcome of bone marrow transplant.

Key features of the study:

  • This report provides in-depth analysis of the global bone marrow transplant market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bone marrow transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Lonza, Merck KgaA, Sanofi, AllCells, STEMCELL Technologies Inc., Charles River Laboratories, Beike Biotechnology Co., Ltd., FUJIFILM Cellular Dynamics, Inc., CORESTEM, Inc., Gamida Cell, Lifeline Cell Technology, Mesoblast Ltd, and PromoCell GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global bone marrow transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone marrow transplant market

Detailed Segmentation:

  • Global Bone Marrow Transplant Market, By Type:
    • Autologous Transplant
    • Allogenic Transplant
    • Others
  • Global Bone Marrow Transplant Market, By Treatment Type:
    • Leukemia
    • Lymphoma
    • Myeloma
    • Myelodysplastic Syndrome
    • Myeloproliferative Disorders
    • Aplastic Anemia
    • Solid Tumors
    • Sickle cell Anemia
    • Thalassemia
    • Others
  • Global Bone Marrow Transplant Market, By End User:
    • Hospitals
    • Multi-specialty Clinics
    • Ambulatory Surgical Centers
  • Global Bone Marrow Transplant Market, By Region:
    • North America
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Lonza*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck KgaA
    • Sanofi
    • AllCells
    • STEMCELL Technologies Inc.
    • Charles River Laboratories
    • Beike Biotechnology Co., Ltd.
    • FUJIFILM Cellular Dynamics, Inc.
    • CORESTEM, Inc.
    • Gamida Cell
    • Lifeline Cell Technology
    • Mesoblast Ltd
    • PromoCell GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Bone Marrow Transplant Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Bone Marrow Transplant Market, By Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Autologous Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Allogenic Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Bone Marrow Transplant Market, By Treatment Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Leukemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Lymphoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Myeloma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Myelodysplastic Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Myeloproliferative Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Aplastic Anemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Solid Tumors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Sickle cell Anemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Thalassemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Bone Marrow Transplant Market, By End User, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Multi-specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Bone Marrow Transplant Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Lonza
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck KgaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AllCells
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STEMCELL Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beike Biotechnology Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • FUJIFILM Cellular Dynamics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CORESTEM, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Gamida Cell
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lifeline Cell Technology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mesoblast Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PromoCell GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategie

10. Section

  • Research Methodology
  • About Us